Semaglutide tablets and non-prescription access: the honest answer

Step 1, understand why a prescription is non-negotiable

The question behind this search is understandable. Wegovy tablets are new, widely covered in the press, and a lot of people want to try them. But semaglutide in any form (tablets, injection, or otherwise) sits firmly in the prescription-only category under UK medicines law. The MHRA licenses these medicines with that classification because they carry real clinical considerations: interactions with other medicines you may take, contraindications that vary by medical history, and a titration schedule that needs monitoring.

Sellers offering semaglutide tablets without asking for a prescription are operating outside the law. The MHRA has been explicit on this point, and its enforcement activity has included raids, seizures and criminal referrals. The risk to you is not just legal: products sold through unregulated channels have been found to contain incorrect or entirely wrong substances. For a medicine you take every day at escalating doses, that is a serious safety issue, not a technicality.

The MHRA's Yellow Card scheme allows anyone to report a suspect seller or an unexpected reaction, it is worth bookmarking if you ever come across an offer that looks too convenient.

Step 2, check whether you meet the licensed criteria

Before starting a consultation anywhere, it helps to know the basic eligibility threshold. The MHRA licensed Wegovy tablets for adults with a BMI of 30 or above, or a BMI of 27 to 29.9 alongside at least one weight-related health condition, things like high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. BMI alone does not guarantee approval; a prescriber reviews the full picture, including current medicines, relevant medical history, and whether this treatment is genuinely appropriate for you.

These criteria sit at the private prescription level. On the NHS, Wegovy tablets are not yet available, no NICE appraisal has been completed for the oral formulation, so access is through a private, regulated service for now. If you want to understand what NHS routes currently look like for weight management medicines, our overview of semaglutide tablets and the NHS covers the current position clearly.

It is also worth noting that Rybelsus (another oral semaglutide product) is licensed for type 2 diabetes at 3 mg, 7 mg and 14 mg. Those strengths and that indication are entirely separate from the Wegovy tablet weight-loss schedule. Confusing the two is easy when both appear in search results; they are not interchangeable.

Step 3, choose a regulated private prescribing service

Once you know you are likely to meet the basic criteria, the practical question becomes where to get a semaglutide tablets prescription. In the UK, legitimate private online prescribing services are registered with the Care Quality Commission (for the clinical side) and dispense through a GPhC-registered pharmacy. You can verify any online pharmacy on the GPhC public register before sharing any personal or medical information.

At nume, a GPhC-registered Independent Prescriber (a named clinician, not a triage algorithm) reviews every consultation personally. If you order before 12pm on a working day and your consultation is clinically approved, treatment is dispatched the same day and delivered free the next working day in plain, unbranded packaging. There are no subscriptions and no auto-renewals; every repeat order goes through a fresh clinical review. You can read more about how to buy semaglutide tablets through a regulated service if you want the detail on the process before you begin.

For a broader look at the oral formulation itself (how it works, what the trial evidence shows, and how it compares to the injection) our guide to Wegovy tablets in the UK covers the clinical picture without the commercial noise. And if you are already certain you want to explore this route, our page on where to buy the Wegovy pill in the UK walks through what to look for in a provider.

Step 4, know what a legitimate consultation actually involves

A proper clinical assessment for semaglutide tablets prescription covers more than a BMI check. You will be asked about current and recent medicines (because the 30-minute pre-dose window matters differently for people on time-sensitive medications), relevant conditions including any history of pancreatitis, gallbladder disease or thyroid issues, and pregnancy or conception plans. The MHRA advises against use during pregnancy, breastfeeding or when actively trying to conceive, and the medicine is not licensed for under-18s.

One practical note on the daily routine: the tablet needs to be taken first thing in the morning on an empty stomach with a small amount of plain water (roughly up to 120 ml) and you then wait at least 30 minutes before eating, drinking anything else, or taking other oral medicines. Unlike the injection, there is no cold chain to manage. Leaving the strip pack by the kettle is a habit that works for many people, though the formal storage guidance is in the Patient Information Leaflet supplied with your medicine. Our clinical team at nume is available for aftercare support seven days a week if questions come up after you start.

The trial evidence published at the time of MHRA approval (from the OASIS 4 phase-3 study) reported around 13.6% average weight loss over 64 weeks compared to placebo, with approximately 17% among participants who stayed fully adherent to the treatment schedule. Those figures come with the usual caveats: clinical trials are controlled environments, and individual results vary. The MHRA's approvals page gives context on the regulatory standards these products must meet before reaching patients. For a wider look at weight management options beyond the tablet, if you are ready to take the next step you can buy a semaglutide tablet through a regulated service after a clinical consultation, and our guide to semaglutide tablets for sale in the UK explains what to look for to make sure any provider you consider meets the required standards. Our treatment overview is a useful starting point for a wider look at weight management options beyond the tablet.